Abstract
Background
Burst suppression in mechanically ventilated intensive care unit (ICU) patients is associated with increased mortality. However, the relative contributions of propofol use and critical illness itself to burst suppression; of burst suppression, propofol, and critical illness to mortality; and whether preventing burst suppression might reduce mortality, have not been quantified.
Methods
The dataset contains 471 adults from seven ICUs, after excluding anoxic encephalopathy due to cardiac arrest or intentional burst suppression for therapeutic reasons. We used multiple prediction and causal inference methods to estimate the effects connecting burst suppression, propofol, critical illness, and in-hospital mortality in an observational retrospective study. We also estimated the effects mediated by burst suppression. Sensitivity analysis was used to assess for unmeasured confounding.
Results
The expected outcomes in a “counterfactual” randomized controlled trial (cRCT) that assigned patients to mild versus severe illness are expected to show a difference in burst suppression burden of 39%, 95% CI [8–66]%, and in mortality of 35% [29–41]%. Assigning patients to maximal (100%) burst suppression burden is expected to increase mortality by 12% [7–17]% compared to 0% burden. Burst suppression mediates 10% [2–21]% of the effect of critical illness on mortality. A high cumulative propofol dose (1316 mg/kg) is expected to increase burst suppression burden by 6% [0.8–12]% compared to a low dose (284 mg/kg). Propofol exposure has no significant direct effect on mortality; its effect is entirely mediated through burst suppression.
Conclusions
Our analysis clarifies how important factors contribute to mortality in ICU patients. Burst suppression appears to contribute to mortality but is primarily an effect of critical illness rather than iatrogenic use of propofol.
Similar content being viewed by others
Code Availability
Code for the algorithm development, evaluation, and statistical analysis is open source with no restrictions and is available from https://github.com/mghcdac/burst_suppression_causal_inference.
References
Watson PL, Shintani AK, Tyson R, Pandharipande PP, Pun BT, Ely EW. Presence of electroencephalogram burst suppression in sedated, critically ill patients is associated with increased mortality. Crit Care Med. 2008;36:3171.
Andresen JM, Girard TD, Pandharipande PP, Davidson MA, Ely EW, Watson PL. Burst suppression on processed electroencephalography as a predictor of post-coma delirium in mechanically ventilated ICU patients. Crit Care Med. 2014;42:2244.
Hernán MA, Robins JM. Causal inference. Boca Raton: Chapman & Hall/CRC; 2019.
Pearl J. Causality. Cambridge: Cambridge University Press; 2009.
VanderWeele TJ. A unification of mediation and interaction: a four-way decomposition. Epidemiology (Cambridge, Mass). 2014;25:749.
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268–74.
Lederer DJ, Bell SC, Branson RD, et al. Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc. 2019;16:22–8.
Hirsch L, LaRoche S, Gaspard N, et al. American clinical neurophysiology society’s standardized critical care EEG terminology: 2012 version. J Clin Neurophysiol. 2013;30:1–27.
Chipman HA, George EI, McCulloch RE. BART: Bayesian additive regression trees. Ann Appl Stat. 2010;4:266–98.
Olson HE, Kelly M, LaCoursiere CM, et al. Genetics and genotype–phenotype correlations in early onset epileptic encephalopathy with burst suppression. Ann Neurol. 2017;81:419–29.
Polito A, Eischwald F, Le Maho A-L, et al. Pattern of brain injury in the acute setting of human septic shock. Crit Care. 2013;17:R204.
Hosokawa K, Gaspard N, Su F, Oddo M, Vincent J-L, Taccone FS. Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care. 2014;18:674.
Wildes TS, Mickle AM, Abdallah AB, et al. Effect of electroencephalography-guided anesthetic administration on postoperative delirium among older adults undergoing major surgery: the engages randomized clinical trial. JAMA. 2019;321:473–83.
Funding
This work was supported by NIH-NINDS (1K23NS090900, 1R01NS102190, 1R01NS102574, 1R01NS107291) to MBW. This work was supported by SAGE Therapeutics to MBW, SZ, and ESR.
Author information
Authors and Affiliations
Contributions
HS, JH, HAN, MBW contributed to data analysis; HAN, JJ, JH, MT, FJ, SK, EB, JG, VMJ, MG, YS, MME, MS, and MBW contributed to data collection; JH, HS, HAN, SZ, and MBW contributed to study design; JH, HS, SZ, and MBW contributed to drafting initial manuscript; all co-authors contributed to manuscript revision.
Corresponding author
Ethics declarations
Conflict of interest
The authors have disclosed that they do not have any competing interests.
Ethical approval/Informed consent
We confirm adherence to ethical guidelines and indicate ethical approvals (IRB) and use of informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hogan, J., Sun, H., Aboul Nour, H. et al. Burst Suppression: Causes and Effects on Mortality in Critical Illness. Neurocrit Care 33, 565–574 (2020). https://doi.org/10.1007/s12028-020-00932-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-020-00932-4